[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.] #  @BioStocks Bio Stocks™ Bio Stocks™ posts on X about $kymr, $prax, $xbi, $tern the most. They currently have XXXXXX followers and XXX posts still getting attention that total XXXXXX engagements in the last XX hours. ### Engagements: XXXXXX [#](/creator/twitter::112872946/interactions)  - X Week XXXXXXX +31% - X Month XXXXXXXXX -XXXX% - X Months XXXXXXXXX +95% - X Year XXXXXXXXX +13% ### Mentions: XX [#](/creator/twitter::112872946/posts_active)  - X Week XXX -XX% - X Month XXX +64% - X Months XXXXX +105% - X Year XXXXX +58% ### Followers: XXXXXX [#](/creator/twitter::112872946/followers)  - X Week XXXXXX +0.16% - X Month XXXXXX +0.40% - X Months XXXXXX +3.60% - X Year XXXXXX +5.80% ### CreatorRank: XXXXXXX [#](/creator/twitter::112872946/influencer_rank)  ### Social Influence **Social category influence** [finance](/list/finance) #4572 [stocks](/list/stocks) #5698 [cryptocurrencies](/list/cryptocurrencies) #2194 [currencies](/list/currencies) XXXX% [vc firms](/list/vc-firms) #263 **Social topic influence** [$kymr](/topic/$kymr) #6, [$prax](/topic/$prax) #7, [$xbi](/topic/$xbi) #2, [$tern](/topic/$tern) #4, [$lly](/topic/$lly) #15, [$barcl](/topic/$barcl) #18, [$axsm](/topic/$axsm) 1.87%, [$azn](/topic/$azn) #41, [$tara](/topic/$tara) #43, [$nvo](/topic/$nvo) #102 **Top accounts mentioned or mentioned by** [@mbrushstocks](/creator/undefined) [@biotechtoast](/creator/undefined) [@_joebaffoe](/creator/undefined) [@biopharmiq](/creator/undefined) [@fwcweather](/creator/undefined) [@biopharma_watch](/creator/undefined) [@tradingsssss](/creator/undefined) [@biotech2k1](/creator/undefined) [@jul05310473john](/creator/undefined) [@polycle](/creator/undefined) [@tim925256475865](/creator/undefined) [@semodough](/creator/undefined) [@learnbiotech](/creator/undefined) [@m56804962](/creator/undefined) [@pgainz96934](/creator/undefined) [@jcannush](/creator/undefined) [@1776americanews](/creator/undefined) [@yaireinhorn](/creator/undefined) [@truedat999](/creator/undefined) [@a_may_md](/creator/undefined) **Top assets mentioned** [Kymera Therapeutics, Inc. Common Stock (KYMR)](/topic/$kymr) [Praxis Precision Medicines, Inc. Common Stock (PRAX)](/topic/$prax) [Bitcoin Incognito (XBI)](/topic/$xbi) [Terns Pharmaceuticals, Inc. Common Stock (TERN)](/topic/$tern) [Eli Lilly and Company (LLY)](/topic/$lly) [Axsome Therapeutics, Inc (AXSM)](/topic/$axsm) [AstraZeneca PLC (AZN)](/topic/$azn) [Taraxa (TARA)](/topic/$tara) [Novo-Nordisk (NVO)](/topic/$nvo) [Wave Life Sciences Ltd. Ordinary Shares (WVE)](/topic/$wve) [Dyne Therapeutics, Inc. Common Stock (DYN)](/topic/$dyn) [Sarepta Therapeutics, Inc. (SRPT)](/topic/$srpt) [AltLayer (ALT)](/topic/$alt) [Vera Therapeutics, Inc. Class A Common Stock (VERA)](/topic/$vera) [Dawn Protocol (DAWN)](/topic/$dawn) [Alkermes Inc. plc (ALKS)](/topic/$alks) [Arrowhead Research Corporation (ARWR)](/topic/$arwr) [Hims & Hers Health, Inc. (HIMS)](/topic/$hims) [Dr. Reddy's Laboratories Limited American Depositary Shares (RDY)](/topic/$rdy) [Viking Therapeutics, Inc (VKTX)](/topic/$vktx) [Ocular Therapeutix, Inc. (OCUL)](/topic/$ocul) [Novartis AG (NVS)](/topic/$nvs) [501 (32)](/topic/$32) [GoodRx Holdings, Inc. Class A Common Stock (GDRX)](/topic/$gdrx) [Curate (XCUR)](/topic/$xcur) [uniQure N.V. (QURE)](/topic/$qure) [Xenon Pharmaceuticals Inc (XENE)](/topic/$xene) [United Therapeutics, Corp. (UTHR)](/topic/$uthr) [Summit Therapeutics Inc. Common Stock (SMMT)](/topic/$smmt) [MoonLake Immunotherapeutics Class A Ordinary Shares (MLTX)](/topic/$mltx) [Biohaven Pharmaceutical Holding Company Ltd. (BHVN)](/topic/$bhvn) [Madrigal Pharmaceuticals, Inc. Common Stock (MDGL)](/topic/$mdgl) [Cidara Therapeutics, Inc. (CDTX)](/topic/$cdtx) [One Cash (ONC)](/topic/$onc) [Natera, Inc. Common Stock (NTRA)](/topic/$ntra) [Insmed, Inc. (INSM)](/topic/$insm) [Teva Pharmaceutical Industries Limited American Depositary Shares (TEVA)](/topic/$teva) [Janux Therapeutics, Inc. Common Stock (JANX)](/topic/$janx) [Ionis Pharmaceuticals, Inc. Common Stock (IONS)](/topic/$ions) [Denali Therapeutics Inc. Common Stock (DNLI)](/topic/$dnli) [Royalty Pharma plc Class A Ordinary Shares (RPRX)](/topic/$rprx) [Marblex (MBX)](/topic/$mbx) [Goldman Sachs (GS)](/topic/goldman-sachs) [Biogen Inc (BIIB)](/topic/$biib) [Incyte Corporation (INCY)](/topic/$incy) ### Top Social Posts Top posts by engagements in the last XX hours "$AXSM obtains exclusive global rights to AZD7325 a novel oral GABAA receptor XX subtype-selective positive allosteric modulator (PAM) licensed from $AZN" [X Link](https://x.com/BioStocks/status/1986403843081437210) 2025-11-06T12:02Z 70.4K followers, 4310 engagements "$TERN $400M offering" [X Link](https://x.com/BioStocks/status/1998351713187852510) 2025-12-09T11:19Z 70.4K followers, 6907 engagements "Indian Court Rejects $NVO's Injunction Plea Allows Dr. Reddy's to Manufacture and Export Generic Versions of Semaglutide. $RDY" [X Link](https://x.com/BioStocks/status/1996546564333126132) 2025-12-04T11:46Z 70.4K followers, 5594 engagements "$KYMR KT-621 BROADEN2 Phase 2b trial in moderate to severe AD is ongoing with data expected by mid-2027. Phase 2b BREADTH trial in moderate to severe asthma patients is on track to start inQ1'26" [X Link](https://x.com/BioStocks/status/1998001703363424413) 2025-12-08T12:08Z 70.4K followers, 4347 engagements "$PRAX #AES25 Wrap-up: Best-in-Class Potential Across Rare Pediatric and Adult Epilepsies" [X Link](https://x.com/BioStocks/status/1998021685791125922) 2025-12-08T13:27Z 70.4K followers, 3213 engagements "$LLY Jaypirca (pirtobrutinib) significantly improved progression-free survival reducing the risk of progression or death by XX% versus chemoimmunotherapy in patients with treatment-nave CLL/SLL" [X Link](https://x.com/BioStocks/status/1998372947111911461) 2025-12-09T12:43Z 70.4K followers, 3905 engagements "$TARA Announces Positive Interim Results Demonstrating Robust Responses in the Ongoing Phase X STARBORN-1 Trial of TARA-002 in Pediatric Patients with Lymphatic Malformations" [X Link](https://x.com/BioStocks/status/1991129677361029186) 2025-11-19T13:01Z 70.4K followers, 5494 engagements "$NVO Phase X trial with amycretin reports significant weight loss and HbA1c reduction in type X diabetes. Amycretin showed statistically significant weight loss of up to XXXX% at XX weeks. $LLY $VKTX" [X Link](https://x.com/BioStocks/status/1993281252695457916) 2025-11-25T11:30Z 70.4K followers, 52.3K engagements "$TARA $75M offering priced at $5.75/share" [X Link](https://x.com/BioStocks/status/1996780186902388744) 2025-12-05T03:14Z 70.4K followers, 5082 engagements "PM movers - $WVE XX% $FULC XX% $KYMR XX $OCUL XX% $DYN XX% $KMDA X% $XBI #biotech" [X Link](https://x.com/BioStocks/status/1998013432688414744) 2025-12-08T12:54Z 70.4K followers, 11.4K engagements "$NVS collaboration with Relation Therapeutics to discover and advance novel targets for atopic diseases. Relation to receive $55M upfront" [X Link](https://x.com/BioStocks/status/1998338239837737362) 2025-12-09T10:25Z 70.4K followers, 4964 engagements "$TERN PT raised to $XX at Barclays" [X Link](https://x.com/BioStocks/status/1998347183255421309) 2025-12-09T11:01Z 70.4K followers, 3559 engagements "$SRPT initiated with an Outperform at Wedbush. PT $32" [X Link](https://x.com/BioStocks/status/1998363365044023347) 2025-12-09T12:05Z 70.4K followers, 4468 engagements "$GDRX covg initiated with an Underweight at Barclays. PT $3" [X Link](https://x.com/BioStocks/status/1998374835928649827) 2025-12-09T12:51Z 70.4K followers, 3354 engagements "$XCUR Completes the Last Patient Last Visit in Phase X Study of GPC-100 for Stem Cell Mobilization in Multiple Myeloma Patients Undergoing Autologous Transplant. Topline data Q4" [X Link](https://x.com/BioStocks/status/1951650838037803397) 2025-08-02T14:26Z 70.4K followers, 3609 engagements "TD Cowen analyst highlights #biotech stocks driving next wave of innovation. $QURE $XENE $UTHR $XBI" [X Link](https://x.com/BioStocks/status/1979546075532013683) 2025-10-18T13:52Z 70.4K followers, 4204 engagements "$CCCC Point72 Asset Management reports XXX% stake" [X Link](https://x.com/BioStocks/status/1980440215048400926) 2025-10-21T01:05Z 70.4K followers, 10.1K engagements "$SMMT $500M PIPE @ $18.74/share. Summits insiders including Akeso invested a total of $282M" [X Link](https://x.com/BioStocks/status/1980968284725060053) 2025-10-22T12:03Z 70.4K followers, 14.1K engagements "$AXSM Anticipated Milestones" [X Link](https://x.com/BioStocks/status/1985336641616277542) 2025-11-03T13:21Z 70.4K followers, 4829 engagements "$RLMD $100M offering priced at $2.20/share" [X Link](https://x.com/BioStocks/status/1985681289706688869) 2025-11-04T12:11Z 70.4K followers, 3542 engagements "$MLTX cash cash equivalents $380.5M Anticipated milestones-" [X Link](https://x.com/BioStocks/status/1986042020553470164) 2025-11-05T12:04Z 70.4K followers, 4488 engagements "$VERA Submits BLA through Accelerated Approval Program for Atacicept for the Treatment of Adults with IgA Nephropathy" [X Link](https://x.com/BioStocks/status/1986940426184761398) 2025-11-07T23:34Z 70.4K followers, 4975 engagements "$BHVN $150M offering" [X Link](https://x.com/BioStocks/status/1988353301440594328) 2025-11-11T21:09Z 70.4K followers, 8070 engagements "$DAWN to Acquire $MRSN for $25/share cash + CVR" [X Link](https://x.com/BioStocks/status/1988925303847072164) 2025-11-13T11:01Z 70.4K followers, 22.6K engagements "$25/share in cash plus up to an aggregate of $30.25/share in cash potentially payable under the CVR for total consideration of up to $55.25/share in cash. $DAWN $MRSN" [X Link](https://x.com/BioStocks/status/1988927205565706494) 2025-11-13T11:09Z 70.4K followers, 6695 engagements "$AVDL Board Declares Lundbeck Proposal a Company Superior Proposal. $ALKS" [X Link](https://x.com/BioStocks/status/1990372774356082892) 2025-11-17T10:53Z 70.4K followers, 9820 engagements "$PRAX initiated with a Buy at BTIG. PT $XXX 🔥 Sees a greater than $5B greenfield opportunity for Ulixacaltamide in essential tremor" [X Link](https://x.com/BioStocks/status/1990928637328011625) 2025-11-18T23:42Z 70.3K followers, 6851 engagements "$ALKS Announces Increased Offer to Acquire $AVDL $22.50/share - consisting of $21/share in cash + $XXXX CVR" [X Link](https://x.com/BioStocks/status/1991099660791074971) 2025-11-19T11:02Z 70.4K followers, 6161 engagements "$MDGL PT raised to $XXX at Oppenheimer" [X Link](https://x.com/BioStocks/status/1991465941658661065) 2025-11-20T11:17Z 70.4K followers, 5643 engagements "$SRPT Progress Update for SRP-1003 its Investigational siRNA treatment for Myotonic Dystrophy Type 1" [X Link](https://x.com/BioStocks/status/1992934573425193150) 2025-11-24T12:33Z 70.4K followers, 8501 engagements "$CDTX Reaches Target Enrollment of Phase X ANCHOR Trial Evaluating CD388 for Prevention of Seasonal Influenza in High-Risk Populations. Interim analysis in Q1" [X Link](https://x.com/BioStocks/status/1992941568521871676) 2025-11-24T13:01Z 70.4K followers, 3052 engagements "$ASND PDUFA extended by three months to 02/28/26" [X Link](https://x.com/BioStocks/status/1993477691237187635) 2025-11-26T00:31Z 70.4K followers, 9156 engagements "$ONC FDA Grants Priority Review to Sonrotoclax NDA for the Treatment of Relapsed or Refractory Mantle Cell Lymphoma" [X Link](https://x.com/BioStocks/status/1993636614229082428) 2025-11-26T11:03Z 70.4K followers, 4137 engagements "30% of Billionaire Stanley Druckenmiller's Portfolio Is Invested in These X Biopharma Stocks $NTRA $INSM $TEVA $XBI" [X Link](https://x.com/BioStocks/status/1995162404569878540) 2025-11-30T16:06Z 70.4K followers, 16.7K engagements "$DARE Announces Return of Rights to Ovaprene by Bayer" [X Link](https://x.com/BioStocks/status/1995478858426974393) 2025-12-01T13:03Z 70.4K followers, 4180 engagements "$ALT CEO to step down effective Jan 1" [X Link](https://x.com/BioStocks/status/1995484636605284530) 2025-12-01T13:26Z 70.4K followers, 4328 engagements "$IONS receives FDA Breakthrough Therapy designation for zilganersen for Alexander disease (AxD)" [X Link](https://x.com/BioStocks/status/1995826406128058825) 2025-12-02T12:04Z 70.4K followers, 3358 engagements "$AZN Baxdrostat NDA accepted under FDA Priority Review for patients with hard-to-control hypertension. PDUFA anticipated in Q2'26 following use of Priority Review voucher" [X Link](https://x.com/BioStocks/status/1995860667447083474) 2025-12-02T14:20Z 70.4K followers, 5544 engagements "$CAPR Pivotal Phase X study (n=106) met the primary endpoint (PUL v2.0) and the key secondary cardiac endpoint (LVEF) both achieving statistical significance (p=0.03 and p=0.04 respectively)" [X Link](https://x.com/BioStocks/status/1996192996241637556) 2025-12-03T12:21Z 70.4K followers, 32.8K engagements "$SPRB upgraded to Outperform at Leerink. PT $160" [X Link](https://x.com/BioStocks/status/1996214358914068956) 2025-12-03T13:46Z 70.4K followers, 4006 engagements "$CBIO $185M PIPE. Forbion Fairmount Vestal Point Capital BVF Partners ADAR1 Balyasny Asset Management and Venrock Healthcare Capital" [X Link](https://x.com/BioStocks/status/1996544493261324562) 2025-12-04T11:37Z 70.4K followers, 11K engagements "$DNLI and $RPRX Announce $275M Royalty Funding Agreement" [X Link](https://x.com/BioStocks/status/1996550431926059232) 2025-12-04T12:01Z 70.4K followers, 3865 engagements "$MBX initiated with a Sell at Goldman Sachs. PT $18" [X Link](https://x.com/BioStocks/status/1996562490529128845) 2025-12-04T12:49Z 70.4K followers, 5689 engagements "$PRAX Wedbush reiterates Underperform. PT $83" [X Link](https://x.com/BioStocks/status/1996940655839662124) 2025-12-05T13:52Z 70.4K followers, 5149 engagements "$PRAX named top pick at BTIG. PT raised to $499" [X Link](https://x.com/BioStocks/status/1996941232917172664) 2025-12-05T13:54Z 70.4K followers, 5616 engagements "$KYMR XX% PM" [X Link](https://x.com/BioStocks/status/1998005046114754636) 2025-12-08T12:21Z 70.4K followers, 3135 engagements "$CYBN $175M PIPE Venrock Partners OrbiMed Point72 Deep Track Capital Acorn Bioventures Spruce Street Capital Squadron Capital Adage Capital Boxer Capital ADAR1 Capital Management Stonepine Capital Management Pivotal Bioventure Partners Ally Bridge Group" [X Link](https://x.com/BioStocks/status/1983142489205649686) 2025-10-28T12:03Z 70.4K followers, 21.7K engagements "$380/yr. 🤑🤑" [X Link](https://x.com/BioStocks/status/1992979172390834425) 2025-11-24T15:30Z 70.4K followers, 277.6K engagements "Eisai Completes Rolling sBLA Submission for LEQEMBI IQLIK (lecanemab-irmb) as a Subcutaneous Starting Dose for the Treatment of Early Alzheimer's Disease Under Fast Track Status. $BIIB" [X Link](https://x.com/BioStocks/status/1993297670933516402) 2025-11-25T12:36Z 70.4K followers, 4278 engagements "$LLY cuts prices of Zepbound weight loss drug vials on direct-to-consumer site. Cash-paying patients with a valid prescription can pay $XXX to $XXX per month for Zepbound vials on LillyDirect. $NVO $HIMS" [X Link](https://x.com/BioStocks/status/1995481917635039417) 2025-12-01T13:15Z 70.4K followers, 11K engagements "$INCY PT raised to $XXX at Wells Fargo" [X Link](https://x.com/BioStocks/status/1998003058341757019) 2025-12-08T12:13Z 70.4K followers, 3013 engagements "$ARWR Initiates Phase 1/2a Study of ARO-MAPT for the Treatment of Alzheimers Disease and Other Tauopathies" [X Link](https://x.com/BioStocks/status/1998008274768339071) 2025-12-08T12:34Z 70.4K followers, 4494 engagements "$HIMS initiated with an Overweight at Barclays. PT $48" [X Link](https://x.com/BioStocks/status/1998212477012914277) 2025-12-09T02:05Z 70.4K followers, 4022 engagements "$LUCD Announces Positive Data from the Largest Reported Real-World Experience of Esophageal Precancer Detection" [X Link](https://x.com/BioStocks/status/1998377596573381107) 2025-12-09T13:02Z 70.4K followers, 10.5K engagements "$ALNY Q3 total net product revenues of $851M. XXX% growth compared with Q3'24. Total TTR revenues of $724M. XXX% YoY" [X Link](https://x.com/BioStocks/status/1983867506017141124) 2025-10-30T12:04Z 70.4K followers, 3967 engagements "$KYMR Announces Positive Results from BroADen Phase 1b Clinical Trial of KT-621 a First-in-Class Oral STAT6 Degrader in Patients with Moderate to Severe Atopic Dermatitis" [X Link](https://x.com/BioStocks/status/1998000070168654276) 2025-12-08T12:01Z 70.4K followers, 25.7K engagements "$PRAX PT raised to $XXX at Truist" [X Link](https://x.com/BioStocks/status/1998018411268583449) 2025-12-08T13:14Z 70.4K followers, 2677 engagements "#Biotech offerings priced - $TERN $650M at $40/share $GPCR $650M at $65/ADS $KYMR $602M at $86/share $WVE $350M at $19/share $DYN $350M at $18.44/share $VERA $261M at $42.50/share $XXXX Billion💥 $XBI" [X Link](https://x.com/BioStocks/status/1998615636621279382) 2025-12-10T04:47Z 70.4K followers, 6229 engagements
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
@BioStocks Bio Stocks™
Bio Stocks™ posts on X about $kymr, $prax, $xbi, $tern the most. They currently have XXXXXX followers and XXX posts still getting attention that total XXXXXX engagements in the last XX hours.
Engagements: XXXXXX #
- X Week XXXXXXX +31%
- X Month XXXXXXXXX -XXXX%
- X Months XXXXXXXXX +95%
- X Year XXXXXXXXX +13%
Mentions: XX #
- X Week XXX -XX%
- X Month XXX +64%
- X Months XXXXX +105%
- X Year XXXXX +58%
Followers: XXXXXX #
- X Week XXXXXX +0.16%
- X Month XXXXXX +0.40%
- X Months XXXXXX +3.60%
- X Year XXXXXX +5.80%
CreatorRank: XXXXXXX #
Social Influence
Social category influence finance #4572 stocks #5698 cryptocurrencies #2194 currencies XXXX% vc firms #263
Social topic influence $kymr #6, $prax #7, $xbi #2, $tern #4, $lly #15, $barcl #18, $axsm 1.87%, $azn #41, $tara #43, $nvo #102
Top accounts mentioned or mentioned by @mbrushstocks @biotechtoast @_joebaffoe @biopharmiq @fwcweather @biopharma_watch @tradingsssss @biotech2k1 @jul05310473john @polycle @tim925256475865 @semodough @learnbiotech @m56804962 @pgainz96934 @jcannush @1776americanews @yaireinhorn @truedat999 @a_may_md
Top assets mentioned Kymera Therapeutics, Inc. Common Stock (KYMR) Praxis Precision Medicines, Inc. Common Stock (PRAX) Bitcoin Incognito (XBI) Terns Pharmaceuticals, Inc. Common Stock (TERN) Eli Lilly and Company (LLY) Axsome Therapeutics, Inc (AXSM) AstraZeneca PLC (AZN) Taraxa (TARA) Novo-Nordisk (NVO) Wave Life Sciences Ltd. Ordinary Shares (WVE) Dyne Therapeutics, Inc. Common Stock (DYN) Sarepta Therapeutics, Inc. (SRPT) AltLayer (ALT) Vera Therapeutics, Inc. Class A Common Stock (VERA) Dawn Protocol (DAWN) Alkermes Inc. plc (ALKS) Arrowhead Research Corporation (ARWR) Hims & Hers Health, Inc. (HIMS) Dr. Reddy's Laboratories Limited American Depositary Shares (RDY) Viking Therapeutics, Inc (VKTX) Ocular Therapeutix, Inc. (OCUL) Novartis AG (NVS) 501 (32) GoodRx Holdings, Inc. Class A Common Stock (GDRX) Curate (XCUR) uniQure N.V. (QURE) Xenon Pharmaceuticals Inc (XENE) United Therapeutics, Corp. (UTHR) Summit Therapeutics Inc. Common Stock (SMMT) MoonLake Immunotherapeutics Class A Ordinary Shares (MLTX) Biohaven Pharmaceutical Holding Company Ltd. (BHVN) Madrigal Pharmaceuticals, Inc. Common Stock (MDGL) Cidara Therapeutics, Inc. (CDTX) One Cash (ONC) Natera, Inc. Common Stock (NTRA) Insmed, Inc. (INSM) Teva Pharmaceutical Industries Limited American Depositary Shares (TEVA) Janux Therapeutics, Inc. Common Stock (JANX) Ionis Pharmaceuticals, Inc. Common Stock (IONS) Denali Therapeutics Inc. Common Stock (DNLI) Royalty Pharma plc Class A Ordinary Shares (RPRX) Marblex (MBX) Goldman Sachs (GS) Biogen Inc (BIIB) Incyte Corporation (INCY)
Top Social Posts
Top posts by engagements in the last XX hours
"$AXSM obtains exclusive global rights to AZD7325 a novel oral GABAA receptor XX subtype-selective positive allosteric modulator (PAM) licensed from $AZN"
X Link 2025-11-06T12:02Z 70.4K followers, 4310 engagements
"$TERN $400M offering"
X Link 2025-12-09T11:19Z 70.4K followers, 6907 engagements
"Indian Court Rejects $NVO's Injunction Plea Allows Dr. Reddy's to Manufacture and Export Generic Versions of Semaglutide. $RDY"
X Link 2025-12-04T11:46Z 70.4K followers, 5594 engagements
"$KYMR KT-621 BROADEN2 Phase 2b trial in moderate to severe AD is ongoing with data expected by mid-2027. Phase 2b BREADTH trial in moderate to severe asthma patients is on track to start inQ1'26"
X Link 2025-12-08T12:08Z 70.4K followers, 4347 engagements
"$PRAX #AES25 Wrap-up: Best-in-Class Potential Across Rare Pediatric and Adult Epilepsies"
X Link 2025-12-08T13:27Z 70.4K followers, 3213 engagements
"$LLY Jaypirca (pirtobrutinib) significantly improved progression-free survival reducing the risk of progression or death by XX% versus chemoimmunotherapy in patients with treatment-nave CLL/SLL"
X Link 2025-12-09T12:43Z 70.4K followers, 3905 engagements
"$TARA Announces Positive Interim Results Demonstrating Robust Responses in the Ongoing Phase X STARBORN-1 Trial of TARA-002 in Pediatric Patients with Lymphatic Malformations"
X Link 2025-11-19T13:01Z 70.4K followers, 5494 engagements
"$NVO Phase X trial with amycretin reports significant weight loss and HbA1c reduction in type X diabetes. Amycretin showed statistically significant weight loss of up to XXXX% at XX weeks. $LLY $VKTX"
X Link 2025-11-25T11:30Z 70.4K followers, 52.3K engagements
"$TARA $75M offering priced at $5.75/share"
X Link 2025-12-05T03:14Z 70.4K followers, 5082 engagements
"PM movers - $WVE XX% $FULC XX% $KYMR XX $OCUL XX% $DYN XX% $KMDA X% $XBI #biotech"
X Link 2025-12-08T12:54Z 70.4K followers, 11.4K engagements
"$NVS collaboration with Relation Therapeutics to discover and advance novel targets for atopic diseases. Relation to receive $55M upfront"
X Link 2025-12-09T10:25Z 70.4K followers, 4964 engagements
"$TERN PT raised to $XX at Barclays"
X Link 2025-12-09T11:01Z 70.4K followers, 3559 engagements
"$SRPT initiated with an Outperform at Wedbush. PT $32"
X Link 2025-12-09T12:05Z 70.4K followers, 4468 engagements
"$GDRX covg initiated with an Underweight at Barclays. PT $3"
X Link 2025-12-09T12:51Z 70.4K followers, 3354 engagements
"$XCUR Completes the Last Patient Last Visit in Phase X Study of GPC-100 for Stem Cell Mobilization in Multiple Myeloma Patients Undergoing Autologous Transplant. Topline data Q4"
X Link 2025-08-02T14:26Z 70.4K followers, 3609 engagements
"TD Cowen analyst highlights #biotech stocks driving next wave of innovation. $QURE $XENE $UTHR $XBI"
X Link 2025-10-18T13:52Z 70.4K followers, 4204 engagements
"$CCCC Point72 Asset Management reports XXX% stake"
X Link 2025-10-21T01:05Z 70.4K followers, 10.1K engagements
"$SMMT $500M PIPE @ $18.74/share. Summits insiders including Akeso invested a total of $282M"
X Link 2025-10-22T12:03Z 70.4K followers, 14.1K engagements
"$AXSM Anticipated Milestones"
X Link 2025-11-03T13:21Z 70.4K followers, 4829 engagements
"$RLMD $100M offering priced at $2.20/share"
X Link 2025-11-04T12:11Z 70.4K followers, 3542 engagements
"$MLTX cash cash equivalents $380.5M Anticipated milestones-"
X Link 2025-11-05T12:04Z 70.4K followers, 4488 engagements
"$VERA Submits BLA through Accelerated Approval Program for Atacicept for the Treatment of Adults with IgA Nephropathy"
X Link 2025-11-07T23:34Z 70.4K followers, 4975 engagements
"$BHVN $150M offering"
X Link 2025-11-11T21:09Z 70.4K followers, 8070 engagements
"$DAWN to Acquire $MRSN for $25/share cash + CVR"
X Link 2025-11-13T11:01Z 70.4K followers, 22.6K engagements
"$25/share in cash plus up to an aggregate of $30.25/share in cash potentially payable under the CVR for total consideration of up to $55.25/share in cash. $DAWN $MRSN"
X Link 2025-11-13T11:09Z 70.4K followers, 6695 engagements
"$AVDL Board Declares Lundbeck Proposal a Company Superior Proposal. $ALKS"
X Link 2025-11-17T10:53Z 70.4K followers, 9820 engagements
"$PRAX initiated with a Buy at BTIG. PT $XXX 🔥 Sees a greater than $5B greenfield opportunity for Ulixacaltamide in essential tremor"
X Link 2025-11-18T23:42Z 70.3K followers, 6851 engagements
"$ALKS Announces Increased Offer to Acquire $AVDL $22.50/share - consisting of $21/share in cash + $XXXX CVR"
X Link 2025-11-19T11:02Z 70.4K followers, 6161 engagements
"$MDGL PT raised to $XXX at Oppenheimer"
X Link 2025-11-20T11:17Z 70.4K followers, 5643 engagements
"$SRPT Progress Update for SRP-1003 its Investigational siRNA treatment for Myotonic Dystrophy Type 1"
X Link 2025-11-24T12:33Z 70.4K followers, 8501 engagements
"$CDTX Reaches Target Enrollment of Phase X ANCHOR Trial Evaluating CD388 for Prevention of Seasonal Influenza in High-Risk Populations. Interim analysis in Q1"
X Link 2025-11-24T13:01Z 70.4K followers, 3052 engagements
"$ASND PDUFA extended by three months to 02/28/26"
X Link 2025-11-26T00:31Z 70.4K followers, 9156 engagements
"$ONC FDA Grants Priority Review to Sonrotoclax NDA for the Treatment of Relapsed or Refractory Mantle Cell Lymphoma"
X Link 2025-11-26T11:03Z 70.4K followers, 4137 engagements
"30% of Billionaire Stanley Druckenmiller's Portfolio Is Invested in These X Biopharma Stocks $NTRA $INSM $TEVA $XBI"
X Link 2025-11-30T16:06Z 70.4K followers, 16.7K engagements
"$DARE Announces Return of Rights to Ovaprene by Bayer"
X Link 2025-12-01T13:03Z 70.4K followers, 4180 engagements
"$ALT CEO to step down effective Jan 1"
X Link 2025-12-01T13:26Z 70.4K followers, 4328 engagements
"$IONS receives FDA Breakthrough Therapy designation for zilganersen for Alexander disease (AxD)"
X Link 2025-12-02T12:04Z 70.4K followers, 3358 engagements
"$AZN Baxdrostat NDA accepted under FDA Priority Review for patients with hard-to-control hypertension. PDUFA anticipated in Q2'26 following use of Priority Review voucher"
X Link 2025-12-02T14:20Z 70.4K followers, 5544 engagements
"$CAPR Pivotal Phase X study (n=106) met the primary endpoint (PUL v2.0) and the key secondary cardiac endpoint (LVEF) both achieving statistical significance (p=0.03 and p=0.04 respectively)"
X Link 2025-12-03T12:21Z 70.4K followers, 32.8K engagements
"$SPRB upgraded to Outperform at Leerink. PT $160"
X Link 2025-12-03T13:46Z 70.4K followers, 4006 engagements
"$CBIO $185M PIPE. Forbion Fairmount Vestal Point Capital BVF Partners ADAR1 Balyasny Asset Management and Venrock Healthcare Capital"
X Link 2025-12-04T11:37Z 70.4K followers, 11K engagements
"$DNLI and $RPRX Announce $275M Royalty Funding Agreement"
X Link 2025-12-04T12:01Z 70.4K followers, 3865 engagements
"$MBX initiated with a Sell at Goldman Sachs. PT $18"
X Link 2025-12-04T12:49Z 70.4K followers, 5689 engagements
"$PRAX Wedbush reiterates Underperform. PT $83"
X Link 2025-12-05T13:52Z 70.4K followers, 5149 engagements
"$PRAX named top pick at BTIG. PT raised to $499"
X Link 2025-12-05T13:54Z 70.4K followers, 5616 engagements
"$KYMR XX% PM"
X Link 2025-12-08T12:21Z 70.4K followers, 3135 engagements
"$CYBN $175M PIPE Venrock Partners OrbiMed Point72 Deep Track Capital Acorn Bioventures Spruce Street Capital Squadron Capital Adage Capital Boxer Capital ADAR1 Capital Management Stonepine Capital Management Pivotal Bioventure Partners Ally Bridge Group"
X Link 2025-10-28T12:03Z 70.4K followers, 21.7K engagements
"$380/yr. 🤑🤑"
X Link 2025-11-24T15:30Z 70.4K followers, 277.6K engagements
"Eisai Completes Rolling sBLA Submission for LEQEMBI IQLIK (lecanemab-irmb) as a Subcutaneous Starting Dose for the Treatment of Early Alzheimer's Disease Under Fast Track Status. $BIIB"
X Link 2025-11-25T12:36Z 70.4K followers, 4278 engagements
"$LLY cuts prices of Zepbound weight loss drug vials on direct-to-consumer site. Cash-paying patients with a valid prescription can pay $XXX to $XXX per month for Zepbound vials on LillyDirect. $NVO $HIMS"
X Link 2025-12-01T13:15Z 70.4K followers, 11K engagements
"$INCY PT raised to $XXX at Wells Fargo"
X Link 2025-12-08T12:13Z 70.4K followers, 3013 engagements
"$ARWR Initiates Phase 1/2a Study of ARO-MAPT for the Treatment of Alzheimers Disease and Other Tauopathies"
X Link 2025-12-08T12:34Z 70.4K followers, 4494 engagements
"$HIMS initiated with an Overweight at Barclays. PT $48"
X Link 2025-12-09T02:05Z 70.4K followers, 4022 engagements
"$LUCD Announces Positive Data from the Largest Reported Real-World Experience of Esophageal Precancer Detection"
X Link 2025-12-09T13:02Z 70.4K followers, 10.5K engagements
"$ALNY Q3 total net product revenues of $851M. XXX% growth compared with Q3'24. Total TTR revenues of $724M. XXX% YoY"
X Link 2025-10-30T12:04Z 70.4K followers, 3967 engagements
"$KYMR Announces Positive Results from BroADen Phase 1b Clinical Trial of KT-621 a First-in-Class Oral STAT6 Degrader in Patients with Moderate to Severe Atopic Dermatitis"
X Link 2025-12-08T12:01Z 70.4K followers, 25.7K engagements
"$PRAX PT raised to $XXX at Truist"
X Link 2025-12-08T13:14Z 70.4K followers, 2677 engagements
"#Biotech offerings priced - $TERN $650M at $40/share $GPCR $650M at $65/ADS $KYMR $602M at $86/share $WVE $350M at $19/share $DYN $350M at $18.44/share $VERA $261M at $42.50/share $XXXX Billion💥 $XBI"
X Link 2025-12-10T04:47Z 70.4K followers, 6229 engagements